VERTEX PHARMACEUTICALS INC / MA (VRTX) Stock buybacks 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$2.0BFY2025 · since FY2016: $0 → $2.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0B | +71.4% |
| FY2024 | $1.2B | +175.3% |
| FY2023 | $427.6M | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.4B | +164.4% |
| FY2020 | $539.1M | +189.8% |
| FY2019 | $186.0M | -46.9% |
| FY2018 | $350.0M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice